Lazard Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.55M | Sell |
340,255
-1,500,673
| -82% | -$40M | 0.02% | 430 |
|
|
2025
Q4 | $45.8M | Buy |
1,840,928
+62,895
| +4% | +$1.59M | 0.08% | 213 |
|
|
2025
Q3 | $45.3M | Buy |
1,778,033
+583,659
| +49% | +$14.4M | 0.06% | 209 |
|
|
2025
Q2 | $29M | Buy |
1,194,374
+314,931
| +36% | +$7.34M | 0.04% | 304 |
|
|
2025
Q1 | $22.3M | Buy |
879,443
+675,243
| +331% | +$17.7M | 0.03% | 327 |
|
|
2024
Q4 | $5.42M | Sell |
204,200
-50,586
| -20% | -$1.37M | 0.01% | 621 |
|
|
2024
Q3 | $7.37M | Sell |
254,786
-14,091
| -5% | -$411K | 0.01% | 537 |
|
|
2024
Q2 | $7.52M | Sell |
268,877
-426,027
| -61% | -$11.7M | 0.01% | 574 |
|
|
2024
Q1 | $19.3M | Sell |
694,904
-1,264,445
| -65% | -$35.1M | 0.02% | 395 |
|
|
2023
Q4 | $56.4M | Sell |
1,959,349
-100,235
| -5% | -$3.03M | 0.07% | 201 |
|
|
2023
Q3 | $68.3M | Sell |
2,059,584
-185,703
| -8% | -$6.57M | 0.09% | 174 |
|
|
2023
Q2 | $82.4M | Buy |
2,245,287
+154,787
| +7% | +$6.02M | 0.1% | 160 |
|
|
2023
Q1 | $85.3M | Buy |
2,090,500
+209,515
| +11% | +$9.05M | 0.11% | 155 |
|
|
2022
Q4 | $96.4M | Buy |
1,880,985
+122,416
| +7% | +$5.87M | 0.13% | 137 |
|
|
2022
Q3 | $77M | Sell |
1,758,569
-156,287
| -8% | -$7.59M | 0.11% | 165 |
|
|
2022
Q2 | $100M | Sell |
1,914,856
-169,091
| -8% | -$8.62M | 0.14% | 136 |
|
|
2022
Q1 | $108M | Buy |
2,083,947
+1,275,423
| +158% | +$66.2M | 0.13% | 152 |
|
|
2021
Q4 | $47.7M | Buy |
808,524
+2,522
| +0.3% | +$125K | 0.05% | 296 |
|
|
2021
Q3 | $34.7M | Sell |
806,002
-714,884
| -47% | -$31.7M | 0.04% | 355 |
|
|
2021
Q2 | $59.6M | Sell |
1,520,886
-1,331,187
| -47% | -$51.8M | 0.07% | 244 |
|
|
2021
Q1 | $103M | Sell |
2,852,073
-485,599
| -15% | -$17.2M | 0.13% | 142 |
|
|
2020
Q4 | $123M | Sell |
3,337,672
-14,953,399
| -82% | -$548M | 0.16% | 124 |
|
|
2020
Q3 | $637M | Buy |
18,291,071
+669,086
| +4% | +$23.5M | 0.9% | 22 |
|
|
2020
Q2 | $547M | Buy |
17,621,985
+2,360,511
| +15% | +$80.2M | 0.84% | 22 |
|
|
2020
Q1 | $473M | Buy |
15,261,474
+2,762,850
| +22% | +$94.1M | 0.87% | 26 |
|
|
2019
Q4 | $465M | Buy |
12,498,624
+4,320,112
| +53% | +$154M | 0.66% | 39 |
|
|
2019
Q3 | $279M | Sell |
8,178,512
-1,710,977
| -17% | -$62.2M | 0.46% | 56 |
|
|
2019
Q2 | $406M | Sell |
9,889,489
-2,075,482
| -17% | -$82.4M | 0.66% | 44 |
|
|
2019
Q1 | $482M | Sell |
11,964,971
-6,060
| -0.1% | -$243K | 0.79% | 36 |
|
|
2018
Q4 | $496M | Sell |
11,971,031
-2,841,143
| -19% | -$118M | 0.91% | 26 |
|
|
2018
Q3 | $619M | Sell |
14,812,174
-628,574
| -4% | -$24.2M | 1% | 24 |
|
|
2018
Q2 | $531M | Sell |
15,440,748
-4,094,793
| -21% | -$140M | 0.92% | 27 |
|
|
2018
Q1 | $658M | Buy |
19,535,541
+1,424,447
| +8% | +$49M | 1.12% | 24 |
|
|
2017
Q4 | $622M | Buy |
18,111,094
+203,883
| +1% | +$6.95M | 1.07% | 25 |
|
|
2017
Q3 | $607M | Sell |
17,907,211
-183,796
| -1% | -$5.91M | 1.1% | 24 |
|
|
2017
Q2 | $577M | Sell |
18,091,007
-13,159,959
| -42% | -$415M | 1.08% | 26 |
|
|
2017
Q1 | $1.01B | Sell |
31,250,966
-5,023,010
| -14% | -$158M | 1.91% | 8 |
|
|
2016
Q4 | $1.12B | Buy |
36,273,976
+8,521,347
| +31% | +$260M | 2.28% | 3 |
|
|
2016
Q3 | $892M | Buy |
27,752,629
+4,304,965
| +18% | +$144M | 1.77% | 11 |
|
|
2016
Q2 | $783M | Sell |
23,447,664
-5,345,159
| -19% | -$171M | 1.65% | 12 |
|
|
2016
Q1 | $810M | Buy |
28,792,823
+4,126,745
| +17% | +$118M | 1.77% | 11 |
|
|
2015
Q4 | $755M | Buy |
24,666,078
+125,359
| +0.5% | +$3.94M | 1.73% | 11 |
|
|
2015
Q3 | $731M | Buy |
24,540,719
+1,573,574
| +7% | +$50.5M | 1.75% | 12 |
|
|
2015
Q2 | $731M | Buy |
22,967,145
+740,609
| +3% | +$24.1M | 1.53% | 14 |
|
|
2015
Q1 | $734M | Buy |
22,226,536
+404,111
| +2% | +$12.8M | 1.58% | 11 |
|
|
2014
Q4 | $645M | Sell |
21,822,425
-1,085,715
| -5% | -$31.1M | 1.38% | 14 |
|
|
2014
Q3 | $643M | Sell |
22,908,140
-6,387,518
| -22% | -$179M | 1.38% | 14 |
|
|
2014
Q2 | $825M | Buy |
29,295,658
+2,637,816
| +10% | +$75.2M | 1.72% | 7 |
|
|
2014
Q1 | $812M | Buy |
26,657,842
+1,271,313
| +5% | +$37.9M | 1.81% | 4 |
|
|
2013
Q4 | $738M | Sell |
25,386,529
-5,443,513
| -18% | -$158M | 1.64% | 6 |
|
|
2013
Q3 | $840M | Sell |
30,830,042
-755,592
| -2% | -$20.6M | 1.99% | 3 |
|
|
2013
Q2 | $839M | Buy |
+31,585,634
| New | +$873M | 1.99% | 5 |
|
Other funds holding PFE
VCM
VPM
Lazard Asset Management's PFE Position: Q1 2026 in Review
Lazard Asset Management reduced its Pfizer (PFE) stake by 82% in Q1 2026, selling an estimated $40M and leaving 340,255 shares worth $9.55M. The position accounts for 0.02% of the portfolio, ranked #430.
Lazard Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.12B in Q4 2016. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Lazard Asset Management held 340,255 shares of Pfizer worth $9.55M as of Q1 2026.
- Lazard Asset Management sold 1,500,673 Pfizer shares in Q1 2026, an estimated $40M.
- Pfizer made up 0.02% of Lazard Asset Management's portfolio in Q1 2026, its #430 holding.
- Lazard Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Lazard Asset Management's Pfizer position peaked at $1.12B in Q4 2016.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.